VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $322 | -99.9% | 43,517 | -1.3% | 0.04% | -27.4% |
| Q3 2022 | $436,000 | -9.2% | 44,082 | 0.0% | 0.06% | -3.1% |
| Q2 2022 | $480,000 | -3.8% | 44,082 | 0.0% | 0.06% | +23.1% |
| Q1 2022 | $499,000 | -27.9% | 44,082 | 0.0% | 0.05% | -17.5% |
| Q4 2021 | $692,000 | -8.5% | 44,082 | 0.0% | 0.06% | -10.0% |
| Q3 2021 | $756,000 | -20.3% | 44,082 | 0.0% | 0.07% | -13.6% |
| Q2 2021 | $948,000 | +43.2% | 44,082 | 0.0% | 0.08% | +35.0% |
| Q1 2021 | $662,000 | +155.6% | 44,082 | +123.7% | 0.06% | +160.9% |
| Q4 2020 | $259,000 | +36.3% | 19,710 | +0.1% | 0.02% | +27.8% |
| Q3 2020 | $190,000 | -15.6% | 19,685 | 0.0% | 0.02% | -14.3% |
| Q2 2020 | $225,000 | +19.7% | 19,685 | +8.3% | 0.02% | +10.5% |
| Q1 2020 | $188,000 | -82.6% | 18,180 | -56.1% | 0.02% | -71.6% |
| Q4 2018 | $1,082,000 | – | 41,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |